Zacks Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$104M Sell
113,388
-1,633
-1% -$1.66M 0.84% 27
2025
Q4
$124M Buy
115,021
+1,323
+1% +$1.27M 0.97% 23
2025
Q3
$86.8M Buy
113,698
+4,244
+4% +$3.16M 0.69% 38
2025
Q2
$85.3M Buy
109,454
+770
+0.7% +$598K 0.73% 34
2025
Q1
$89.8M Buy
108,684
+3,873
+4% +$3.22M 0.84% 33
2024
Q4
$80.9M Sell
104,811
-9,144
-8% -$7.57M 0.75% 34
2024
Q3
$101M Buy
113,955
+10,211
+10% +$9.18M 0.88% 30
2024
Q2
$93.9M Buy
103,744
+7,586
+8% +$6.07M 1.06% 25
2024
Q1
$74.8M Buy
96,158
+8,762
+10% +$6.24M 0.8% 32
2023
Q4
$50.9M Sell
87,396
-1,478
-2% -$863K 0.63% 46
2023
Q3
$47.7M Buy
88,874
+1,581
+2% +$815K 0.62% 48
2023
Q2
$40.9M Buy
87,293
+34,491
+65% +$14.5M 0.51% 56
2023
Q1
$18.1M Sell
52,802
-41,268
-44% -$13.9M 0.24% 105
2022
Q4
$34.4M Buy
94,070
+3,550
+4% +$1.26M 0.48% 63
2022
Q3
$29.3M Buy
90,520
+1,964
+2% +$622K 0.47% 64
2022
Q2
$28.7M Buy
88,556
+21,930
+33% +$6.58M 0.44% 69
2022
Q1
$19.1M Buy
66,626
+7,377
+12% +$1.9M 0.26% 93
2021
Q4
$16.4M Buy
59,249
+18,957
+47% +$4.81M 0.23% 107
2021
Q3
$9.31M Buy
40,292
+38,503
+2,152% +$9.5M 0.15% 140
2021
Q2
$411K Buy
1,789
+39
+2% +$7.83K 0.01% 476
2021
Q1
$327K Buy
1,750
+23
+1% +$4.5K 0.01% 452
2020
Q4
$292K Sell
1,727
-27,734
-94% -$4.14M 0.01% 469
2020
Q3
$4.36M Sell
29,461
-42,293
-59% -$6.55M 0.09% 154
2020
Q2
$11.8M Sell
71,754
-20,372
-22% -$3.13M 0.26% 94
2020
Q1
$12.8M Sell
92,126
-572
-0.6% -$78.6K 0.31% 82
2019
Q4
$12.2M Buy
92,698
+2,580
+3% +$299K 0.23% 96
2019
Q3
$10.1M Buy
90,118
+2,686
+3% +$299K 0.2% 107
2019
Q2
$9.69M Buy
87,432
+2,590
+3% +$305K 0.2% 105
2019
Q1
$11M Sell
84,842
-232,994
-73% -$28.3M 0.24% 97
2018
Q4
$36.8M Sell
317,836
-504
-0.2% -$56.3K 0.89% 36
2018
Q3
$34.2M Buy
318,340
+77,039
+32% +$7.7M 0.71% 47
2018
Q2
$20.6M Buy
241,301
+2,335
+1% +$192K 0.45% 72
2018
Q1
$18.5M Buy
238,966
+3,288
+1% +$265K 0.41% 75
2017
Q4
$19.9M Buy
235,678
+4,349
+2% +$370K 0.43% 68
2017
Q3
$19.8M Buy
231,329
+3,131
+1% +$257K 0.46% 65
2017
Q2
$18.8M Buy
228,198
+4,590
+2% +$374K 0.47% 67
2017
Q1
$18.8M Buy
223,608
+26,122
+13% +$2.09M 0.48% 65
2016
Q4
$14.5M Sell
197,486
-6,613
-3% -$492K 0.42% 67
2016
Q3
$16.4M Buy
204,099
+17,276
+9% +$1.38M 0.46% 66
2016
Q2
$14.7M Buy
186,823
+4,585
+3% +$345K 0.45% 68
2016
Q1
$13.1M Buy
182,238
+3,781
+2% +$286K 0.42% 71
2015
Q4
$15M Sell
178,457
-1,426
-0.8% -$118K 0.49% 62
2015
Q3
$15.1M Sell
179,883
-191,583
-52% -$16.2M 0.52% 64
2015
Q2
$31M Sell
371,466
-4,313
-1% -$329K 0.98% 27
2015
Q1
$27.3M Buy
375,779
+14,724
+4% +$1.05M 0.86% 36
2014
Q4
$24.9M Buy
361,055
+26,209
+8% +$1.77M 0.81% 38
2014
Q3
$21.7M Buy
334,846
+24,030
+8% +$1.52M 0.76% 40
2014
Q2
$19.3M Sell
310,816
-15,433
-5% -$921K 0.69% 41
2014
Q1
$19.2M Sell
326,249
-4,026
-1% -$225K 0.71% 37
2013
Q4
$16.8M Buy
330,275
+16,529
+5% +$828K 0.66% 39
2013
Q3
$15.8M Buy
313,746
+18,339
+6% +$960K 0.68% 35
2013
Q2
$14.5M Buy
+295,407
New +$16.1M 0.67% 33

Other funds holding LLY

Zacks Investment Management's LLY Position: Q1 2026 in Review

Zacks Investment Management reduced its Eli Lilly (LLY) stake by 1.4% in Q1 2026, selling an estimated $1.66M and leaving 113,388 shares worth $104M. The position accounts for 0.84% of the portfolio, ranked #27.

Zacks Investment Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $124M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Zacks Investment Management held 113,388 shares of Eli Lilly worth $104M as of Q1 2026.
  • Zacks Investment Management sold 1,633 Eli Lilly shares in Q1 2026, an estimated $1.66M.
  • Eli Lilly made up 0.84% of Zacks Investment Management's portfolio in Q1 2026, its #27 holding.
  • Zacks Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Zacks Investment Management's Eli Lilly position peaked at $124M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.